Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

Some new information,


Major MS Seminar coming up in Spain,

Oct 7, 2015 - The impact of 2015 criteria for Neuromyelitis optica spectrum disorders ...... An open-label add-on trial of cetirizine for neuromyelitis optica: baseline data and ..... Comparative gene expression profiling between Glatopa™ and.

Sorry, My eyes could not take trying to find the subject in 124 pages. I tried twice.

http://www.professionalabstracts.com/ectrims2015/programme-ectrims2015.pdf

Other news,

Added Oct

http://www.myriversidehealth.com/Portals/0/Files/Upcoming%20Formulary%20Changes%20Provider%20Notification%2010-1-2015.pdf


https://www.valleyhealthplan.org/sites/grp/pn/Pharm/Documents/Pharmacy/VHP_EMP_Formulary%2009.01.2015%20MSP.pdf

Glatopa Tier 1 and Copaxone moved to Tier 3,

https://securews.bcbswny.com/web/content/dam/COMMON/Drug%20Therapy%20Guidelines/Formulary%20Updates/Exclusive%20Formulary%20Updates.pdf

Added 9/1

http://www.sfhp.org/files/providers/formulary/SpecialtyDrugListUpdateSummary.pdf

https://www.ucare.org/SiteCollectionDocuments/HealthPlans/UFS/2015/U6423A_WebsiteFormularyChangeAdditions_UFSGroup.pdf

Boing X 2